CBV regimen
WikiDoc Resources for CBV regimen |
Articles |
---|
Most recent articles on CBV regimen Most cited articles on CBV regimen |
Media |
Powerpoint slides on CBV regimen |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on CBV regimen at Clinical Trials.gov Clinical Trials on CBV regimen at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on CBV regimen
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on CBV regimen Discussion groups on CBV regimen Patient Handouts on CBV regimen Directions to Hospitals Treating CBV regimen Risk calculators and risk factors for CBV regimen
|
Healthcare Provider Resources |
Causes & Risk Factors for CBV regimen |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]
Synonyms and keywords: BCNU/CTX/VP-16; Carmustine/Cyclophosphamide/Etoposide; CBV
Overview
CBV regimen refers to Cytoxan (cyclophosphamide), BCNU (carmustine), and VP-16 (etoposide), three drugs in a chemotherapy regimen commonly given to lymphoma patients in conjunction with stem cell therapy.[1]
Regimen
Indications
References
- ↑ Skeel, Roland T. Handbook of Cancer Chemotherapy, 6th Edition. Philadelphia: Lipincott, Williams, & Wilkins, 2003. Page 172-3, Table 5.4: "Common preparative regimens for high-dose therapy without total-body irradiation."